Data from eight areas in the United States served by population-based cancer reporting systems indicate that, after many years of relative stability, incidence rates of endometrial cancer have risen sharply in the 1970's. In some areas the amount of the increase has exceeded 10 per cent per year. The incidence among middle-aged women has changed most (by 40 to 150 per cent between 1969 and 1973, depending on the area), but rates have increased in younger women and the elderly as well.
This article has been cited by other articles:
Strom, B. L., Schinnar, R., Weber, A. L., Bunin, G., Berlin, J. A., Baumgarten, M., DeMichele, A., Rubin, S. C., Berlin, M., Troxel, A. B., Rebbeck, T. R.
(2006). Case-Control Study of Postmenopausal Hormone Replacement Therapy and Endometrial Cancer. Am J Epidemiol
164: 775-786
[Abstract][Full Text]
Rebbeck, T. R., Troxel, A. B., Wang, Y., Walker, A. H., Panossian, S., Gallagher, S., Shatalova, E. G., Blanchard, R., Bunin, G., DeMichele, A., Rubin, S. C., Baumgarten, M., Berlin, M., Schinnar, R., Berlin, J. A., Strom, B. L.
(2006). Estrogen sulfation genes, hormone replacement therapy, and endometrial cancer risk.. JNCI J Natl Cancer Inst
98: 1311-1320
[Abstract][Full Text]
Sivridis, E., Giatromanolaki, A.
(2004). Endometrial Adenocarcinoma: Beliefs and Scepticism. INT J SURG PATHOL
12: 99-105
[Abstract]
Bush, T. L., Whiteman, M., Flaws, J. A.
(2001). Hormone Replacement Therapy and Breast Cancer: A Qualitative Review. Obstet Gynecol
98: 498-508
[Abstract][Full Text]
Feeley, K M, Wells, M
(2001). Hormone replacement therapy and the endometrium. J. Clin. Pathol.
54: 435-440
[Abstract][Full Text]
McKean-Cowdin, R., Feigelson, H. S., Ross, R. K., Pike, M. C., Henderson, B. E.
(2000). Declining Cancer Rates in the 1990s. JCO
18: 2258-2268
[Abstract][Full Text]
Henderson, B. E., Feigelson, H. S.
(2000). Hormonal carcinogenesis. Carcinogenesis
21: 427-433
[Abstract][Full Text]
Gail, M. H., Costantino, J. P., Bryant, J., Croyle, R., Freedman, L., Helzlsouer, K., Vogel, V.
(1999). Weighing the Risks and Benefits of Tamoxifen Treatment for Preventing Breast Cancer. JNCI J Natl Cancer Inst
91: 1829-1846
[Abstract][Full Text]